Table 1 Correlations between PKD1 expression and clinicopathological characteristics of human head and neck cancer
From: Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma
| Â | Number | Score of PKD1 expression | P |
|---|---|---|---|
Gender | |||
 Female | 18 | 4.611 ± 0.852 | 0.116 |
 Male | 105 | 3.514 ± 0.248 | |
Age | |||
  ≤ 35 | 12 | 3.083 ± 0.988 | 0.579 (Group I vs. Group 2) |
 35–55 | 79 | 3.557 ± 0.325 | 0.629 (Group I vs. Group 3) |
  ≥ 55 | 36 | 3.527 ± 0.353 | 0.958 (Group 2 vs. Group 3) |
Depth of invasion | |||
 T1 + T2 | 45 | 4.644 ± 0.287 | 0.063 |
 T3 + T4 | 41 | 3.512 ± 0.269 | |
Clinical stages | |||
 Grade I | 24 | 3.521 ± 0.462 | 0.253 (Grade I vs. Grade II) |
 Grade II | 19 | 4.447 ± 0.476 | 0.726 (Grade I vs. Grade III) |
 Grade III | 43 | 3.756 ± 0.455 | 0.341 (Grade II vs. Grade III) |